China National Center for Cardiovascular Diseases: Cardiomyopathies trials

The registry lists 11 Cardiomyopathies studies with China National Center for Cardiovascular Diseases as lead sponsor. 6 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 1Phase 4 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Use of SGLT2i in noHCM With HFpEFRecruitingNCT06401343Phase 4
• Efficacy and Safety of Thoracoscopic Morrow Surgery in the Treatment of Hypertrophic Obstructive CardiomyopathyRecruitingNCT06391788Not applicable
• Percutaneous Endocardial Septal Radiofrequency Ablation in Obstructive Hypertrophic CardiomyopathyRecruitingNCT06224621Not applicable
• The China CardioMyopathy Registry StudyNot yet recruitingNCT05871632
• Concomitant Hybrid Versus Catheter Ablation for Atrial Fibrillation With Hypertrophic CardiomyopathyRecruitingNCT05610215Not applicable
• The Chinese Hypertrophic Cardiomyopathy Study(CHCS)RecruitingNCT02696135
• SMCs With LVH Compared to HCMActive, not recruitingNCT07006974
• Healthcare Utilization and Costs Among Hospitalized Patients With CardiomyopathyCompletedNCT06893731
• An Observational Study of Subcutaneous Implantable Cardioverter Defibrillator in Patients with Hypertrophic Cardiomyopathy At High Risk of Sudden Cardiac DeathActive, not recruitingNCT06604169
• Association Between Microvascular Resistance and Outcomes in Patients With Obstructive Hypertrophic CardiomyopathyCompletedNCT05671367
• CABG Combined Pedicled Omentum Wrapped Autologous Atrial Tissue Patch Cardiomyoplasty for Ischemic CardiomyopathyStatus unknownNCT00972114Phase 1/2